Opaleye Management’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$225K Sell
2022
Q1
$1.05M Sell
2021
Q4
$2.48M Hold
2021
Q3
$3.18M Sell
2021
Q2
$5.13M Sell
2021
Q1
$7.85M Sell
2020
Q4
$6.92M Sell
2020
Q3
$7.68M Hold
2020
Q2
$8.77M Buy
2020
Q1
$5.46M Buy
2019
Q4
$11.8M Buy
2019
Q3
$7.19M Hold
2019
Q2
$11.2M Sell
2019
Q1
$13.4M Buy
2018
Q4
$6.21M Buy